UTI, particularly pyelonephritis, can cause rejection, sepsis, impaired RTx function, allograft loss and death. We investigated the incidence of UTIs (lower versus upper tract) and effect on allograft function.
INTRODUCTION AND OBJECTIVES: NGS allows a comprehensive analysis of the genomic profile of rectal microbiota and, most importantly, the identification of resistance genes to the standard antibacterial empiric prophylaxis. The aim of our pilot study was to evaluate NGS of rectal swabs in patients before transrectal biopsy of the prostate, seeking to prevent urinary tract infection (UTI).
METHODS: Between June 2017 and September 2018, 68 patients were prospectively entered into this study before scheduled prostate biopsy. The rectal swabs were processed by MicroGenDX, performing diagnostics via NGS. The profiling of the population of bacterial species, including antibiotic resistance genes, provides for a susceptibility determination that clinicians can adjust using local antibiograms and/or clinical references. The standard protocol for prevention of infection included levofloxacin 0.5g orally and 1g ceftriaxone intramuscularly, with adjustment for targeted prophylaxis in each case. RESULTS: In all 68 patients, multiple bacterial species were reported, with a median of 10 (range: 2-16). The predominant flora most frequently found was Bacteroides spp. (dorei, fragilis, caccae, massiliensis, uniformis, and vulgatus) in 26 men; Escherichia coli in 18; and Prevotella (copri, timonensis, and corporis) in 11. In 47/68 (69%) men, multiple drug resistance genes were detected. In 32/68 (47%) men, resistance to fluoroquinolones was reported; in 5/68 (7%) men, resistance to b-lactams (without concomitant resistance to fluoroquinolones) was noted; and in 21/68 (31%) patients there was resistance to both groups. These data allowed us to modify our empiric prophylaxis in those 37 patients targeting the most dominant aggressive pathogen(s). In 27 men, fungal species were detected -15 of these patients harbored multiple fungal species. The presence of a fungal species was used as an indication to supplement prophylaxis with an anti-fungal agent. This NGS-guided prophylaxis strategy was associated with avoidance of serious infectious complications, including urosepsis, in all patients within 30 days after biopsy. Two patients developed epididymitis, and there was only one case of cystitis.
CONCLUSIONS: NGS allowed the implementation of truly individualized and targeted prophylaxis for patients undergoing transrectal biopsy. Further studies will be required to compare the efficacy of NGS to standard methods of culture and sensitivity of rectal swabs.
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MP77-02 ANTIBIOTIC SELECTION USING NEXT GENERATION SEQUENCING VERSUS URINE CULTURE FOR STEWARDSHIP PRIOR TO SURGERY USING AN INTERPROFESSIONAL MODEL
Michael Liss*, San Antonio, TX; Kelley Reveles, Austin, TX;INTRODUCTION AND OBJECTIVES: Despite antibiotic prophylaxis, we have noted an increase in patients presenting with infectious complications after urologic stone procedures despite negative urine cultures. Herein, we determine if next-generation sequencing (NGS) could identify bacteria in negative urine culture that would alter prophylactic antibiotic selection.
METHODS: We performed NGS and PCR for common resistance genes in subjects prior to ureteroscopy. Of the urine being sent for culture, approximately 5-10mL was sent to Microgen Dx for the analysis. NGS results were blinded to the physician and analysis was done after surgery. Surgery, as scheduled per the physician and prophylaxis antibiotics, was prescribed as the standard of care. After the surgery, we made 3 case studies that were reviewed by ten board-certified Urologists to determine if they would change their prophylactic antibiotic regimen and what antibiotic they would prescribe. Two infectious disease pharmacists also reviewed the case reports and provided the ideal antibiotic regimen to be prescribed.
RESULTS: After IRB approval, we obtained samples from urine specimens provided as a preoperative urine culture from twenty patients scheduled for urologic stone surgery. Two culture returned positive with Enterococcus and the NGS result was the same. One sample had two species (enterococcus and coagulase-negative Staphylococcus), in which NGS was able to find both organisms and speciated the staphylococcus to be staphylococcus epidermidus. Of the 18 cultures with no grow 56% (10/18) did show a dominant-bacteria on NGS. Eight urologists returned the three case scenarios and in each of the 3 cases 100%, 88%, and 88% of the physicians would have prescribed a different prophylaxis antibiotic given these results. The ideal antibiotic of choice based on the ID Pharmacist is oral Bactrim for all cases, yet only 50%, 0%,
